Question

Which of the following drug interactions should be carefully monitored when administering antivirals for Herpes and Cytomegalovirus, especially in the context of potential nephrotoxicity, concomitant use with zidovudine, and co-administration with aminoglycosides?

Option 1: A) Combining antivirals with nephrotoxic drugs poses no additional risk.

Option 2: B) Zidovudine can enhance the antiviral effects without any increased risk of nephrotoxicity.

Option 3: C) Concurrent use of aminoglycosides with antivirals may lead to synergistic nephrotoxicity.

Option 4: D) There is no need for monitoring when using these antivirals with other medications.

Answer 1

Certain drug interactions should be carefully monitored when administering antivirals for Herpes and Cytomegalovirus, including potential nephrotoxicity, concomitant use with zidovudine, and co-administration with aminoglycosides.

Step-by-step explanation:

When administering antivirals for Herpes and Cytomegalovirus, certain drug interactions should be carefully monitored, especially in the context of potential nephrotoxicity, concomitant use with zidovudine, and co-administration with aminoglycosides.

1. Option 1: Combining antivirals with nephrotoxic drugs poses no additional risk.
2. Option 2: Zidovudine can enhance the antiviral effects without any increased risk of nephrotoxicity.
3. Option 3: Concurrent use of aminoglycosides with antivirals may lead to synergistic nephrotoxicity.
4. Option 4: There is no need for monitoring when using these antivirals with other medications.